HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon.
Medicine (Baltimore)
; 102(22): e33897, 2023 Jun 02.
Article
in En
| MEDLINE
| ID: mdl-37266631
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
HIV-1
/
Anti-HIV Agents
Type of study:
Observational_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Africa
Language:
En
Journal:
Medicine (Baltimore)
Year:
2023
Document type:
Article
Affiliation country:
Cameroon
Country of publication:
United States